1. Intraperitoneal chemotherapy in peritoneal malignancy: impact of intensive system care on practicability.
- Author
-
Knüsli C, Ruff P, Laffer U, Stoll HR, Obrist R, Weber W, and Obrecht JP
- Subjects
- Adult, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Carboplatin, Catheters, Indwelling, Cisplatin administration & dosage, Drug Evaluation, Female, Follow-Up Studies, Humans, Male, Middle Aged, Organoplatinum Compounds administration & dosage, Peritoneal Neoplasms drug therapy, Retrospective Studies, Critical Care, Fluorouracil administration & dosage, Gastrointestinal Neoplasms drug therapy, Ovarian Neoplasms drug therapy, Peritoneal Neoplasms secondary
- Abstract
In a group of 31 patients a port-a-cath-system for intraperitoneal chemotherapy was installed. From 23 evaluable patients 9 showed a tumor remission, but only 1 was a patient with gastrointestinal carcinoma. All others were patients with ovarial carcinoma. The median survival rate of all patients was 9 months after implantation of the intraperitoneal catheter. 50% of all patients with gastrointestinal carcinoma died within the first 6 months, only 1 of 11 patients with ovarial carcinoma died in this period.
- Published
- 1989